Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Cohance Lifesciences Price Movement Clarification

Cohance Lifesciences clarified that no pending information exists regarding the recent increase in trading volume. The company remains compliant with SEBI regulations.

Source

BSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹480.00
Market cap
₹18,365 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
172.9×Sector 46.1×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other price movement clarification announcements

All →